LEADER 01475nam  2200409   450 
001 9910707366103321
005 20160715080455.0
035   $a(CKB)5470000002463856
035   $a(OCoLC)953616489
035   $a(OCoLC)995470000002463856
035   $a(EXLCZ)995470000002463856
100   $a20160715d2007      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aMedicare reimbursement for existing end stage renal disease drugs $ethird quarter 2006
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2007.
215   $a1 online resource (iii, 16 pages) $cillustrations
300   $aTitle from title screen (viewed June 23, 2016).
300   $a"June 2007."
300   $a"OEI-03-06-00590."
320   $aIncludes bibliographical records.
517   $aMedicare reimbursement for existing end stage renal disease drugs 
606   $aMedicare$xClaims administration
606   $aChronic renal failure$xTreatment$zUnited States$xFinance
606   $aDrugs$zUnited States$xCosts
615  0$aMedicare$xClaims administration.
615  0$aChronic renal failure$xTreatment$xFinance.
615  0$aDrugs$xCosts.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707366103321
996   $aMedicare reimbursement for existing end stage renal disease drugs$93310623
997   $aUNINA